Literature DB >> 10524417

Evaluation of the therapeutic effect of radiotherapy on cervical cancer using magnetic resonance imaging.

K Hatano1, Y Sekiya, H Araki, M Sakai, T Togawa, Y Narita, Y Akiyama, S Kimura, H Ito.   

Abstract

PURPOSE: This study was performed to evaluate magnetic resonance imaging (MRI) in determining the therapeutic effect of radiotherapy (RT) on cervical cancer. METHODS AND MATERIALS: Serial MRI studies were performed in 42 patients with predominantly advanced cervical cancer before, during, and after radiotherapy. Patients underwent external irradiation combined with high-dose-rate intracavitary (HDR) brachytherapy. T-2 weighted spin-echo pulse sequences with long repetition and echo times were used at a field strength of 1.5 T. Multiple punch biopsies of the cervix were obtained from the high-signal intensity area in all patients at the same time as the MRI. RESULT: In biopsies performed immediately after RT, no residual tumors were found in 36 patients (86%); in 6 patients, residual tumors were observed. The simultaneous MRI study demonstrated no high-signal intensity on T2-weighted images in 28 patients. A high-signal area was observed in 14 patients, and this disappeared 3 months after RT in 8 patients with a negative histological study. The sensitivity, specificity, and accuracy of MRI studies at 3 months after RT were 100%. When the relationship between reduction of tumor volume at 30 Gy and local tumor control was analyzed, every patient with a reduction under 30% gained local control. Also, patients with no residual tumors 3 months after RT gained local control.
CONCLUSION: MRI studies performed at 30 Gy of external irradiation and 3 months after RT were predictive factors of local control.

Entities:  

Mesh:

Year:  1999        PMID: 10524417     DOI: 10.1016/s0360-3016(99)00228-x

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  25 in total

1.  Sequential magnetic resonance imaging of cervical cancer: the predictive value of absolute tumor volume and regression ratio measured before, during, and after radiation therapy.

Authors:  Jian Z Wang; Nina A Mayr; Dongqing Zhang; Kaile Li; John C Grecula; Joseph F Montebello; Simon S Lo; William T C Yuh
Journal:  Cancer       Date:  2010-11-01       Impact factor: 6.860

2.  Clinical significance of tumor volume and lymph node involvement assessed by MRI in stage IIB cervical cancer patients treated with concurrent chemoradiation therapy.

Authors:  Dae Woo Lee; Young Tae Kim; Jae Hoon Kim; Sunghoon Kim; Sang Wun Kim; Eun Ji Nam; Jae Wook Kim
Journal:  J Gynecol Oncol       Date:  2010-03-31       Impact factor: 4.401

3.  Clinical and survival impact of FDG PET in patients with suspicion of recurrent cervical carcinoma.

Authors:  Amandine Pallardy; Caroline Bodet-Milin; Aurore Oudoux; Loïc Campion; Emmanuelle Bourbouloux; Christine Sagan; Catherine Ansquer; Aude Testard; Isabelle Resche; Boumédiène Bridji; Françoise Kraeber-Bodéré; Caroline Rousseau
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-03-20       Impact factor: 9.236

4.  Assessment of tumor regression by consecutive pelvic magnetic resonance imaging and dose modification during high-dose-rate brachytherapy for carcinoma of the uterine cervix.

Authors:  Taek-Keun Nam; Byung-Sik Nah; Ho-Sun Choi; Woong-Ki Chung; Sung-Ja Ahn; Seok-Mo Kim; Ju-Young Song; Mi-Seon Yoon
Journal:  Cancer Res Treat       Date:  2005-06-30       Impact factor: 4.679

5.  Residual tumour volumes and grey zones after external beam radiotherapy (with or without chemotherapy) in cervical cancer patients. A low-field MRI study.

Authors:  M P Schmid; B Mansmann; M Federico; J C A Dimopoulous; P Georg; E Fidarova; W Dörr; R Pötter
Journal:  Strahlenther Onkol       Date:  2013-01-25       Impact factor: 3.621

6.  Translating response during therapy into ultimate treatment outcome: a personalized 4-dimensional MRI tumor volumetric regression approach in cervical cancer.

Authors:  Nina A Mayr; Jian Z Wang; Simon S Lo; Dongqing Zhang; John C Grecula; Lanchun Lu; Joseph F Montebello; Jeffrey M Fowler; William T C Yuh
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-07-23       Impact factor: 7.038

7.  Imaging across the life span: innovations in imaging and therapy for gynecologic cancer.

Authors:  Meng Xu-Welliver; William T C Yuh; Julia R Fielding; Katarzyna J Macura; Zhibin Huang; Ahmet S Ayan; Floor J Backes; Guang Jia; Mariam Moshiri; Jun Zhang; Nina A Mayr
Journal:  Radiographics       Date:  2014 Jul-Aug       Impact factor: 5.333

8.  Usefulness of F-18 FDG PET/CT in Assessment of Recurrence of Cervical Cancer After Treatment.

Authors:  Minkyung Lee; Yukyung Lee; Kyung Hoon Hwang; Wonsick Choe; Chan Yong Park
Journal:  Nucl Med Mol Imaging       Date:  2011-01-28

9.  Dynamic contrast-enhanced and diffusion-weighted MRI for early detection of tumoral changes in single-dose and fractionated radiotherapy: evaluation in a rat rhabdomyosarcoma model.

Authors:  F De Keyzer; V Vandecaveye; H Thoeny; F Chen; Y Ni; G Marchal; R Hermans; S Nuyts; W Landuyt; H Bosmans
Journal:  Eur Radiol       Date:  2009-06-06       Impact factor: 5.315

10.  Correlation between clinical findings and magnetic resonance imaging for the assessment of local response after standard treatment in cervical cancer.

Authors:  Izaskun Valduvieco; Albert Biete; Iván Rios; Ricardo Llorente; Angels Rovirosa; Jaume Pahisa; Laura Vidal; Blanca Farrús; Pilar Samper
Journal:  Rep Pract Oncol Radiother       Date:  2013-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.